CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer.

Journal:

Cancer Research

Published:

2025-11-17

DOI:

10.1158/0008-5472.can-25-1835

Affiliations:

9

Authors:

25

Go to article

Institutions	Authors	Share
University of Cincinnati (UC), United States of America (USA)	14.000000 14.000000	0.56
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	8.000000	0.32
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	2.000000	0.08
Medical University of South Carolina (MUSC), United States of America (USA)	1.000000	0.04

Interested in Oncology and Carcinogenesis?